[Clinical effect of the tranquilizer mepiprazol in hospitalized chronic schizophrenis].
D000328:Adult; D000704:Analysis of Variance; D001519:Behavior / Q000187:drug effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects; D010919:Placebos; D011720:Pyrazoles / Q000008:administration & dosage* / Q000009:adverse effects; D012559:Schizophrenia / Q000188:drug therapy*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000008:administration & dosage* / Q000009:adverse effects
D010879:Piperazines; D010919:Placebos; D011720:Pyrazoles; D014149:Tranquilizing Agents
Das klinische Wirkungsbild des Tranquilizers Mepiprazol bei hospitalisierten chronischen Schizophrenen.